| 2026-08-17 | Press release | Labcorp to Host Investor Day on September 10, 2026 |
| 2026-08-17 | 8-K | Form 8-K, Item 7.01 |
| 2026-08-14 | 8-K | Form 8-K, Item 5.02 |
| 2026-08-10 | Press release | Labcorp Announces FDA Approval of Companion Diagnostic Supporting Patients with Advanced Melanoma |
| 2026-08-05 | 10-Q | Form 10-Q for the quarter ended Jun 30 |
| 2026-08-04 | Press release | Labcorp Launches FDA-Approved PTEN Companion Diagnostic for Prostate Cancer |
| 2026-07-30 | Press release | Labcorp Announces 2026 Second Quarter Results; Raises Full Year 2026 Guidance |
| 2026-07-30 | 8-K | Form 8-K, Item 2.02 results |
| 2026-07-30 | Transcript | Q2 FY26 earnings call transcript |
| 2026-07-27 | Press release | Labcorp Launches Marker by Labcorp™ Genetic Health Panel, Expanding Consumer Access to Hereditary Genetic Risk Testing |
| 2026-07-10 | 8-K | Form 8-K, Item 7.01 |
| 2026-07-09 | Press release | Labcorp Declares Quarterly Dividend |
| 2026-06-30 | Press release | Labcorp to Announce Second Quarter 2026 Financial Results on July 30, 2026 |
| 2026-06-30 | 8-K | Form 8-K, Item 7.01 |
| 2026-06-22 | Press release | Labcorp Announces Nationwide Availability of ColoSense®, the First FDA-Approved RNA-Based At-Home Colorectal Cancer Scre |
| 2026-05-29 | Press release | Labcorp Supports Multi-Institution Trial to Expand Genetic Testing in Colorectal Cancer |
| 2026-05-28 | Press release | Labcorp Launches Expanded DPYD Test to Identify Cancer Patients at Risk for Severe Chemotherapy Side Effects |
| 2026-05-27 | 8-K | Form 8-K, Item 7.01 |
| 2026-05-26 | 8-K | Form 8-K, Item 5.07 |
| 2026-05-04 | 10-Q | Form 10-Q for the quarter ended Mar 31 |
| 2026-04-30 | 8-K | Form 8-K, Item 2.02 results |
| 2026-04-10 | Proxy | Definitive proxy statement |
| 2026-04-09 | 8-K | Form 8-K, Item 7.01 |
| 2026-03-31 | 8-K | Form 8-K, Item 7.01 |
| 2026-03-20 | 8-K | Form 8-K, Item 1.01 |
| 2026-02-24 | 10-K | Annual report on Form 10-K, FY25 |
| 2026-02-18 | Transcript | Q4 FY25 earnings call transcript |
| 2026-02-17 | 8-K | Form 8-K, Item 2.02 results |
| 2026-02-09 | 8-K | Form 8-K, Item 5.02 |
| 2026-01-29 | 8-K | Form 8-K, Item 1.01 |
| 2026-01-15 | 8-K | Form 8-K, Item 7.01 |
| 2026-01-14 | 8-K | Form 8-K, Item 7.01 |
| 2025-12-30 | 8-K | Form 8-K, Item 7.01 |
| 2025-12-15 | 8-K | Form 8-K, Item 5.02 |
| 2025-12-10 | 8-K | Form 8-K, Item 5.02 |
| 2025-11-24 | 8-K | Form 8-K, Item 5.02 |
| 2025-10-31 | 10-Q | Form 10-Q for the quarter ended Sep 30 |
| 2025-10-28 | 8-K | Form 8-K, Item 2.02 results |
| 2025-10-08 | 8-K | Form 8-K, Item 7.01 |
| 2025-09-25 | 8-K | Form 8-K, Item 7.01 |